{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:44:47Z","timestamp":1793724287020,"version":"4.6.1"},"reference-count":61,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wroc\u0142aw Medical University, Poland","award":["SUBZ.D110.25.050"],"award-info":[{"award-number":["SUBZ.D110.25.050"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Alzheimer\u2019s disease (AD) is a complex neurodegenerative disorder marked by cholinergic deficits, oxidative stress, amyloid-\u03b2 (A\u03b2) aggregation, and tau hyperphosphorylation. Caffeic acid (CA), a naturally occurring hydroxycinnamic acid, has emerged as a promising neuroprotective candidate due to its antioxidant, anti-inflammatory, and enzyme-inhibitory properties. This review systematically evaluates recent in vitro and in vivo evidence regarding the therapeutic potential of CA in AD models and examines the impact of delivery systems and derivatives on its efficacy and bioavailability. Materials and Methods: A systematic literature search was conducted in the PubMed, Scopus, and Web of Science databases, adhering to the PRISMA 2020 guidelines. Studies published between January 2021 and April 2025 were included in this review. Eligible studies investigated the effects of CA or CA-enriched extracts on AD-relevant mechanisms using in vitro, in vivo, and in silico models. After screening 101 articles, 44 met the inclusion criteria and were included in the final qualitative synthesis of the study. Results: In vitro studies have confirmed that CA modulates cholinergic activity by inhibiting AChE and BChE and exerting antioxidant and anti-amyloidogenic effects. In vivo studies using pharmacological, genetic, and metabolic AD models have demonstrated improvements in cognitive function, reduction in oxidative stress, inflammation, and A\u03b2 and tau pathologies following CA administration. Advanced delivery platforms, such as solid lipid nanoparticles, transferrin-functionalized liposomes, and carbon dot systems, have significantly enhanced CA\u2019s brain bioavailability and therapeutic efficacy. CA derivatives, including caffeic acid phenethyl ester and nitro-substituted analogs, exhibit improved pharmacokinetic and neuroprotective profiles. Conclusions: This review provides evidence supporting the use of CA as a promising multitarget agent against AD pathology. Its therapeutic potential is further enhanced by nanotechnology-based delivery systems and chemical modifications that overcome the limitations of bioavailability. Continued preclinical evaluation and translational studies are warranted to support its clinical development as an AD intervention.<\/jats:p>","DOI":"10.3390\/medicina61081428","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T11:41:53Z","timestamp":1754653313000},"page":"1428","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Experimental Evidence of Caffeic Acid\u2019s Neuroprotective Activity in Alzheimer\u2019s Disease: In Vitro, In Vivo, and Delivery-Based Insights"],"prefix":"10.3390","volume":"61","author":[{"given":"Adam","family":"Kowalczyk","sequence":"first","affiliation":[{"name":"Department of Pharmacognosy and Herbal Medicines, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8097-3333","authenticated-orcid":false,"given":"Carlo Ignazio Giovani","family":"Tuberoso","sequence":"additional","affiliation":[{"name":"Unit of Pharmaceutical, Department of Life and Environmental Sciences, Pharmacological and Nutraceutical Sciences, University of Cagliari, 09042 Monserrato, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Jerkovi\u0107","sequence":"additional","affiliation":[{"name":"Mediterranean Institute for Life Sciences, University of Split, 21000 Split, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Fanlo-Ucar, H., Pic\u00f3n-Pag\u00e8s, P., Herrera-Fern\u00e1ndez, V., ILL-Raga, G., and Mu\u00f1oz, F.J. (2024). The dual role of amyloid beta-peptide in oxidative stress and inflammation: Unveiling their connections in Alzheimer\u2019s disease etiopathology. Antioxidants, 13.","DOI":"10.3390\/antiox13101208"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1515\/revneuro-2019-0089","article-title":"Amyloid-\u03b2, tau, and the cholinergic system in Alzheimer\u2019s disease: Seeking direction in a tangle of clues","volume":"31","author":"Majdi","year":"2020","journal-title":"Rev. Neurosci."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Jurc\u0103u, M.C., Andronie-Cioara, F.L., Jurc\u0103u, A., Marcu, F., \u0162i\u021b, D.M., Pa\u0219cal\u0103u, N., and Nistor-Cseppent\u00f6, D.C. (2022). The Link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: Therapeutic implications and future perspectives. Antioxidants, 11.","DOI":"10.3390\/antiox11112167"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1872208316666220302115901","article-title":"Challenges and approaches of drugs such as memantine, donepezil, rivastigmine, and aducanumab in the treatment, control and management of Alzheimer\u2019s disease","volume":"16","year":"2022","journal-title":"Recent Pat. Biotechnol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/13543784.2023.2178414","article-title":"Lecanemab (BAN2401): An anti\u2013beta-amyloid monoclonal antibody for the treatment of Alzheimer disease","volume":"32","author":"Vitek","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Caruso, G., Godos, J., Privitera, A., Lanza, G., Castellano, S., Chillemi, A., Bruni, O., Ferri, R., Caraci, F., and Grosso, G. (2022). Phenolic acids and prevention of cognitive decline: Polyphenols with a neuroprotective role in cognitive disorders and Alzheimer\u2019s disease. Nutrients, 14.","DOI":"10.3390\/nu14040819"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Sova, M., and Saso, L. (2020). Natural sources, pharmacokinetics, biological activities and health benefits of hydroxycinnamic acids and their metabolites. Nutrients, 12.","DOI":"10.3390\/nu12082190"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Khan, A., Park, J.S., Kang, M.H., Lee, H.J., Ali, J., Tahir, M., Choe, K., and Kim, M.O. (2023). Caffeic acid, a polyphenolic micronutrient rescues mice brains against A\u03b2-induced neurodegeneration and memory impairment. Antioxidants, 12.","DOI":"10.3390\/antiox12061284"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Sharifi-Rad, J., Rapposelli, S., Sestito, S., Herrera-Bravo, J., Arancibia-Diaz, A., Salazar, L.A., Yeskaliyeva, B., Beyatli, A., Leyva-G\u00f3mez, G., and Gonz\u00e1lez-Contreras, C. (2022). Multi-target mechanisms of phytochemicals in Alzheimer\u2019s disease: Effects on oxidative stress, neuroinflammation and protein aggregation. J. Pers. Med., 12.","DOI":"10.3390\/jpm12091515"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gomes, T.M., Sousa, P., Campos, C., Perestrelo, R., and C\u00e2mara, J.S. (2024). Secondary bioactive metabolites from foods of plant origin as theravention agents against neurodegenerative disorders. Foods, 13.","DOI":"10.3390\/foods13142289"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/BPL-200099","article-title":"Low molecular weight (poly)phenol metabolites across the blood-brain barrier: The underexplored journey","volume":"6","author":"Carecho","year":"2021","journal-title":"Brain Plast."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Grabska-Kobylecka, I., Kaczmarek-Bak, J., Figlus, M., Prymont-Przyminska, A., Zwolinska, A., Sarniak, A., Wlodarczyk, A., Glabinski, A., and Nowak, D. (2020). The Presence of caffeic acid in cerebrospinal fluid: Evidence that dietary polyphenols can cross the blood-brain barrier in humans. Nutrients, 12.","DOI":"10.3390\/nu12051531"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"105836","DOI":"10.1016\/j.neuint.2024.105836","article-title":"Unlocking the potential of low-molecular-weight (Poly)phenol metabolites: Protectors at the blood-brain barrier frontier","volume":"179","author":"Marques","year":"2024","journal-title":"Neurochem. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1039\/D3FO01913F","article-title":"Identification and quantification of (poly)phenol and methylxanthine metabolites in human cerebrospinal fluid: Evidence of their ability to cross the BBB","volume":"14","author":"Carregosa","year":"2023","journal-title":"Food Funct."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"10356","DOI":"10.1039\/D1FO02017J","article-title":"Phenolic compounds that cross the blood-brain barrier exert positive health effects as central nervous system antioxidants","volume":"12","year":"2021","journal-title":"Food Funct."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e087881","DOI":"10.1002\/alz.087881","article-title":"Novel piperazine-benzoquinone derivative as a possible lead molecule selectively targeting AChE for the management of dementia in Alzheimer \u2019s disease","volume":"20","author":"Silakari","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Liu, X., Xu, J., Yu, C., Dai, C., Chen, J., Zhong, J., Yang, Y., Huiling Lin, H., Chen, X., and Zhang, Q. (2025). A novel carbamate-based hybrid derivative with anti-neuroinflammatory properties as a selective butyrylcholinesterase inhibitor for Alzheimer\u2019s disease therapy. Bioorg. Chem., 161.","DOI":"10.1016\/j.bioorg.2025.108551"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"37299","DOI":"10.1021\/acsomega.4c05089","article-title":"Repurposing duloxetine as a potent butyrylcholinesterase inhibitor: Potential cholinergic enhancing benefits for elderly individuals with depression and cognitive impairment","volume":"9","author":"Baidya","year":"2024","journal-title":"ACS Omega"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3897\/pharmacia.71.e119755","article-title":"Qualitative chemical compounds analysis and in vitro estimation of antiproliferative, antidiabetic and anti-Alzheimer\u2019s disease effects of Ononis natrix (L.) family Fabaceae","volume":"71","author":"Youssef","year":"2024","journal-title":"Pharmacia"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Al-Rajhi, A.M.H., Qanash, H., Almashjary, M.N., Hazzazi, M.S., Felemban, H.R., and Abdelghany, T.M. (2023). Anti-Helicobacter pylori, antioxidant, antidiabetic, and anti-Alzheimer\u2019s activities of laurel leaf extract treated by moist heat and molecular docking of its flavonoid constituent, naringenin, against acetylcholinesterase and butyrylcholinesterase. Life, 13.","DOI":"10.3390\/life13071512"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Karageili, H., Yilmaz, M.A., Erturk, A., Kiziltas, H., Cuven, L., Alwasel, S.H., and Gulcin, I. (2023). Comprehensive metabolite profiling of Berdav propolis using LC-MS\/MS: Determination of antioxidant, anticholinergic, antiglaucoma, and antidiabetic effects. Molecules, 28.","DOI":"10.3390\/molecules28041739"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19362","DOI":"10.1039\/D4RA03638G","article-title":"Exploring beetroot (Beta vulgaris L.) for diabetes mellitus and Alzheimer\u2019s disease dual therapy: In vitro and computational studies","volume":"14","author":"Ojo","year":"2024","journal-title":"RSC Adv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jsps.2021.01.007","article-title":"In vitro biological activity of Salvia fruticosa Mill. infusion against amyloid \u03b2-peptide-induced toxicity and inhibition of GSK-3\u03b2, CK-1\u03b4, and BACE-1 enzymes relevant to Alzheimer\u2019s disease","volume":"29","author":"Perez","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biopha.2016.03.017","article-title":"Samardeep Caffeic acid attenuates oxidative stress, learning and memory deficit in intra-cerebroventricular streptozotocin induced experimental dementia in rats","volume":"81","author":"Deshmukh","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Rezaee, N., Hone, E., Sohrabi, H.R., Johnson, S., Zhong, L., Chatur, P., Gunzburg, S., Martins, R.N., and Binosha Fernando, W.M.A.D. (2024). Sorghum grain polyphenolic extracts demonstrate neuroprotective effects related to Alzheimer\u2019s disease in cellular assays. Foods, 13.","DOI":"10.3390\/foods13111716"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Swaraz, A.M., Sultana, F., Bari, M.W., Ahmed, K.S., Hasan MIslam, M.M., Islam, M.A., Satter, M.A., Hossain, M.d.H., Islam, M.d.S., and Khan, M.d.I. (2021). Phytochemical profiling of Blumea laciniata (Roxb.) DC. and its phytopharmaceutical potential against diabetic, obesity, and Alzheimer\u2019s. Biomed. Pharmacother., 141.","DOI":"10.1016\/j.biopha.2021.111859"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chupeerach, C., Aursalung, A., Watcharachaisoponsiri, T., Whanmek, K., Thiyajai, P., Yosphan, K., Sritalahareuthai, V., Sahasakul, Y., Santivarangkna, C., and Suttisansanee, U. (2021). The effect of steaming and fermentation on nutritive values, antioxidant activities, and inhibitory properties of tea leaves. Foods, 10.","DOI":"10.3390\/foods10010117"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Zhao, J., Li, Z., Zhang, R., Yu, H., and Zhang, L. (2025). Network pharmacology mechanism of Rosmarinus officinalis L.(Rosemary) to improve cell viability and reduces apoptosis in treating Alzheimer\u2019s disease. BMC Complement. Med. Ther., 25.","DOI":"10.1186\/s12906-025-04771-8"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s11030-024-10818-8","article-title":"Deciphering the multi-functional role of Indian propolis for the management of Alzheimer\u2019s disease by integrating LC\u2013MS\/MS, network pharmacology, molecular docking, and in-vitro studies","volume":"28","author":"Sankaran","year":"2024","journal-title":"Mol. Divers."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.lfs.2008.12.001","article-title":"Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation","volume":"84","author":"Sul","year":"2009","journal-title":"Life Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.phrs.2017.11.028","article-title":"Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer\u2019s disease","volume":"129","author":"Sadhukhan","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Rezaee, N., Hone, E., Sohrabi, H., Abdulraheem, R., Johnson, S.K., Gunzburg, S., Martins, R.N., and Binosha Fernando, W.M.A.D. (2025). Investigating the impact of sorghum on tau protein phosphorylation and mitochondrial dysfunction modulation in Alzheimer\u2019s disease: An in vitro study. Nutrients, 17.","DOI":"10.3390\/nu17030516"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1080\/07391102.2023.2217925","article-title":"Constituents of Stachys plants as potential dual inhibitors of AChE and NMDAR for the treatment of Alzheimer\u2019s disease: A molecular docking and dynamic simulation study","volume":"42","author":"Touati","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"123284","DOI":"10.1016\/j.talanta.2022.123284","article-title":"Rapid screening for acetylcholinesterase inhibitors in Selaginella doederleinii Hieron by using functionalized magnetic Fe3O4 nanoparticles","volume":"243","author":"Zhang","year":"2022","journal-title":"Talanta"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e15909","DOI":"10.1016\/j.heliyon.2023.e15909","article-title":"Evaluation of potential inhibitory effects on acetylcholinesterase, pancreatic lipase, and cancer cell lines using raw leaves extracts of three fabaceae species","volume":"9","author":"Fatima","year":"2023","journal-title":"Heliyon"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Callizot, N., Campanari, M.L., Rouvi\u00e8re, L., Jacquemot, G., Henriques, A., Garayev, E., and Poindron, P. (2021). Huperzia serrata Extract \u2018NSP01\u2019 with neuroprotective effects-potential synergies of huperzine a and polyphenols. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.681532"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1080\/07391102.2020.1801509","article-title":"The impact of some phenolic compounds on serum acetylcholinesterase: Kinetic analysis of an enzyme\/inhibitor interaction and molecular docking study","volume":"39","author":"Beydemir","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1007\/s12035-023-03696-y","article-title":"Implication of caffeic acid for the prevention and treatment of Alzheimer\u2019s disease: Understanding the binding with human transferrin using in silico and in vitro approaches","volume":"61","author":"Shamsi","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Shaji, D., Das, A., Suzuki, R., Nagura, Y., Sabishiro, H., and Kurita, N. (2023). Proposal of novel ApoE4 inhibitors from the natural spice Cinnamon for the treatment of Alzheimer\u2019s disease: Ab initio molecular simulations. Biophys. Chem., 296.","DOI":"10.1016\/j.bpc.2023.106990"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Akomolafe, S.F. (2017). The effects of caffeine, caffeic acid, and their combination on acetylcholinesterase, adenosine deaminase and arginase activities linked with brain function. J. Food Biochem., 41.","DOI":"10.1111\/jfbc.12401"},{"key":"ref_41","first-page":"169","article-title":"Inducing agents for Alzheimer\u2019s disease in animal models","volume":"9","author":"Khan","year":"2024","journal-title":"J. Explor. Res. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"11772","DOI":"10.3390\/cimb46110699","article-title":"Neuroprotective effect of Ixeris dentata extract on trimethyltin-induced memory impairment in rats","volume":"46","author":"Ye","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s12035-023-03601-7","article-title":"Neuroprotection by polyherbal medicine divya-medha-vati against scopolamine-induced cognitive impairment through modulation of oxidative stress, acetylcholine activity, and cell signaling","volume":"61","author":"Balkrishna","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1515\/jcim-2024-0231","article-title":"Exploration of neuroprotective and cognition boosting effects of Mazus pumilus in Alzheimer\u2019s disease model","volume":"21","author":"Saadullah","year":"2024","journal-title":"J. Complement. Integr. Med."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Mahnashi, M.H., Ashraf, M., Alhasaniah, A.H., Ullah, H., Zeb, A., Ghufran, M., Fahad, S., Ayaz, M., and Daglia, M. (2023). Polyphenol-enriched Desmodium elegans DC. ameliorate scopolamine-induced amnesia in animal model of Alzheimer\u2019s disease: In vitro, in vivo and in silico approaches. Biomed. Pharmacother., 165.","DOI":"10.1016\/j.biopha.2023.115144"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Teng, Y., Yuan, Q., Wu, Y., Wu, S., Su, J., Zhang, P., and Zhang, Y. (2023). Research on the chemical constituents against Alzheimer\u2019s Disease of the fruits of Physalis alkekengi L. var. franchetii (Mast.) Makino. Chem. Biodivers., 20.","DOI":"10.1002\/cbdv.202301075"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jphs.2022.12.006","article-title":"Caffeic acid protects against atherosclerotic lesions and cognitive decline in ApoE\u2212\/\u2212mice","volume":"151","author":"Sun","year":"2023","journal-title":"J. Pharmacol. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"175895","DOI":"10.1016\/j.ejphar.2023.175895","article-title":"Systems pharmacology-based mechanism exploration of Acanthopanax senticosusin for Alzheimer\u2019s disease using UPLC-Q-TOF-MS, network analysis, and experimental validation","volume":"954","author":"Zhuo","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/1354750X.2022.2077446","article-title":"Neuroprotective properties of solanum leaves in transgenic Drosophila melanogaster model of Alzheimer\u2019s disease","volume":"27","author":"Ogunsuyi","year":"2022","journal-title":"Biomarkers"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1039\/D0FO02784G","article-title":"Caffeic acid protects against A\u03b2 toxicity and prolongs lifespan in: Caenorhabditis elegans models","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14786419.2025.2477211","article-title":"Phytochemical profiling, in silico molecular docking and ADMET prediction of alkaloid rich fraction of Elaeocarpus angustifolius blume seeds against Alzheimer\u2019s disease","volume":"11","author":"Banu","year":"2025","journal-title":"Nat. Prod. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"100588","DOI":"10.1016\/j.phyplu.2024.100588","article-title":"Peanut meal-derived bioactive compounds: Extraction, co-extrusion encapsulation and neuroprotection against aluminum-induced Alzheimer\u2019s disease via in silico and in vivo studies","volume":"4","author":"Mohamed","year":"2024","journal-title":"Phytomed. Plus"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Grzelczyk, J., Szwajgier, D., Baranowska-W\u00f3jcik, E., P\u00e9rez-S\u00e1nchez, H., Carmena-Bargue\u00f1o, M., Sosnowska, B., and Budryn, G. (2023). Effect of inhibiting butyrylcholinesterase activity using fractionated coffee extracts digested in vitro in gastrointestinal tract: Docking simulation and calorimetric and studies. Nutrients, 15.","DOI":"10.3390\/nu15102366"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Kadar, M.A.N.N., Ahmad, F., Teoh, S.L., and Yahaya, M.F. (2022). Comparable benefits of stingless bee honey and caffeic acid in mitigating the negative effects of metabolic syndrome on the brain. Antioxidants, 11.","DOI":"10.3390\/antiox11112154"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11011-023-01336-x","article-title":"Chitosan\/PLA-loaded magnesium oxide nanocomposite to attenuate oxidative stress, neuroinflammation and neurotoxicity in rat models of Alzheimer\u2019s disease","volume":"39","author":"Rajkumar","year":"2024","journal-title":"Metab. Brain Dis."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"El-Nashar, H.A.S., Abbas, H., Zewail, M., Noureldin, M.H., Ali, M.M., Shamaa, M.M., Khattab, M.A., and Ibrahim, N. (2022). Neuroprotective effect of Artichoke-based nanoformulation in sporadic Alzheimer\u2019s disease mouse model: Focus on antioxidant, anti-inflammatory, and amyloidogenic pathways. Pharmaceuticals, 15.","DOI":"10.3390\/ph15101202"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Hu, Y., Cui, J., Sun, J., Liu, X., Gao, S., Mei, X., Wu, C., and Tian, H. (2024). A novel biomimetic nanovesicle containing caffeic acid-coupled carbon quantum dots for the the treatment of Alzheimer\u2019s disease via nasal administration. J. Nanobiotechnol., 22.","DOI":"10.1186\/s12951-024-02912-8"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Andrade, S., Pereira, M.C., and Loureiro, J.A. (2023). Caffeic acid loaded into engineered lipid nanoparticles for Alzheimer\u2019s disease therapy. Colloids Surf. B Biointerfaces, 225.","DOI":"10.1016\/j.colsurfb.2023.113270"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Wang, H., Zhang, M., Fang, J., He, Y., Liu, M., Hong, Z., and Chai, Y. (2022). Simultaneous determination of seven lipophilic and hydrophilic components in Salvia miltiorrhiza Bunge by LC-MS\/MS method and its application to a transport study in a blood-brain-barrier cell model. Molecules, 27.","DOI":"10.3390\/molecules27030657"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"119929","DOI":"10.1016\/j.lfs.2021.119929","article-title":"CAPE-pNO2 ameliorates diabetic brain injury through modulating Alzheimer\u2019s disease key proteins, oxidation, inflammation and autophagy via a Nrf2-dependent pathway","volume":"287","author":"Luo","year":"2021","journal-title":"Life Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1428\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:26:26Z","timestamp":1760034386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":61,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["medicina61081428"],"URL":"https:\/\/doi.org\/10.3390\/medicina61081428","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}